Latest filing published 18 Dec 2015 for Humanigen, INC, €268k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Marek Biestek: trading record in brief
Marek Biestek discloses dealings in Humanigen, Inc to SEC (Form 4). Between 16 November 2015 and 16 December 2015, the trades on record add up to 4 filings.
No open-market sale appears; the market trades are 4 purchases worth €659k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
A typical purchase (the median) is worth €157k.
The latest filing, published on 18 December 2015, reports an open-market purchase of €268k in Humanigen, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Marek Biestek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$29.32Common StockSEC:0001144204-15-071682:0Canonical exit: 15 Mar 2016 (T+90)
- 40,000 shares@ US$2.04Common StockSEC:0001144204-15-066918:0Canonical exit: 16 Feb 2016 (T+90)
- 65,000 shares@ US$1.36Common StockSEC:0001144204-15-066896:0Canonical exit: 14 Feb 2016 (T+90)
- 135,000 shares@ US$1.83Common StockSEC:0001144204-15-066896:1Canonical exit: 15 Feb 2016 (T+90)
4 of 4 declarations